Pages that link to "Q46248271"
Jump to navigation
Jump to search
The following pages link to Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis (Q46248271):
Displaying 50 items.
- Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis (Q21144604) (← links)
- Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal (Q27012487) (← links)
- Integrated therapy for HIV and cryptococcosis (Q28077707) (← links)
- HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings (Q28078958) (← links)
- Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis (Q28274334) (← links)
- A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi (Q28534417) (← links)
- A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi (Q28538813) (← links)
- Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy (Q30240687) (← links)
- Cryptococcal meningitis: epidemiology and therapeutic options (Q33633343) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant (Q34399223) (← links)
- Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis (Q34415736) (← links)
- Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda (Q34516367) (← links)
- Methods of rapid diagnosis for the etiology of meningitis in adults (Q34554521) (← links)
- Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings (Q34801921) (← links)
- Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis (Q35097032) (← links)
- Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal Meningitis (Q35230534) (← links)
- Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis (Q35628245) (← links)
- The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis (Q35635476) (← links)
- Treatment principles for Candida and Cryptococcus (Q35664186) (← links)
- Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa (Q35674504) (← links)
- AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial (Q35776693) (← links)
- Cryptococcal Meningitis: Diagnosis and Management Update. (Q35951094) (← links)
- Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence (Q36094655) (← links)
- Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis (Q36290487) (← links)
- Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis (Q36326762) (← links)
- Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis (Q36407524) (← links)
- Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis (Q36807382) (← links)
- CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). (Q37041199) (← links)
- Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America (Q37105884) (← links)
- New Insights into HIV/AIDS-Associated Cryptococcosis (Q37156556) (← links)
- A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis (Q37182083) (← links)
- Asymptomatic cryptococcemia in resource-limited settings (Q37259640) (← links)
- Diagnosis and Management of Cryptococcal Relapse (Q37409922) (← links)
- Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). (Q37469829) (← links)
- Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes (Q37579943) (← links)
- Combinatorial strategies for combating invasive fungal infections. (Q37705303) (← links)
- New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis (Q38024052) (← links)
- Cryptococcal infections: changing epidemiology and implications for therapy. (Q38098090) (← links)
- Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries (Q38111887) (← links)
- New facets of antifungal therapy (Q38797864) (← links)
- Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings. (Q38851467) (← links)
- Forgotten but not gone: HIV-associated cryptococcal meningitis (Q39102135) (← links)
- Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level. (Q39395608) (← links)
- Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis (Q40728787) (← links)
- Dectin-2 polymorphism associated with pulmonary cryptococcosis in HIV-uninfected Chinese patients (Q41130260) (← links)
- Voriconazole: a novel treatment option for cryptococcal meningitis. (Q41145601) (← links)
- Combination antifungal therapy for cryptococcal meningitis (Q41924502) (← links)
- Efficacy of Amphotericin B at Suboptimal Dose Combined with Voriconazole in a Murine Model of Aspergillus fumigatus Infection with Poor In Vivo Response to the Azole (Q42573050) (← links)
- Companion drugs for amphotericin B in cryptococcal meningitis: flucytosine, fluconazole, or...Nothing? (Q43037743) (← links)